Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | EVP & Pres. Medical Surgical | December 08, 2023 | December 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date December 08, 2023 · Filed December 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 48,410 |
Reported balance
After 2023-12-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-12-08 · Tax withholding · Disposed 369 · Balance 48,410 F1: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. F2: Includes 814 units acquired through dividend reinvestment since the last report filed by the reporting person. |
| Ordinary SharesSEC Table I · non-derivative | IndirectFamily Trust | 1,500 |
Reported balance
Holding disclosure · report date 2023-12-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,500 F3: Represents securities owned by the White Family Legacy Trust of which the reporting person is the co-trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility.
F2: Includes 814 units acquired through dividend reinvestment since the last report filed by the reporting person.
F3: Represents securities owned by the White Family Legacy Trust of which the reporting person is the co-trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2023 Filed Dec 12, 2023 14:55 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 369 | $79.27 | $29,250.63 |
DisclosureSEC source: 0001613103-23-000164 · wk-form4_1702410897.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,410 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. F2 · balance_after: Includes 814 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:23 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Units · Derivative | 5,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000101 · wk-form4_1691454193.xml · derivative · entry 4 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 5,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F5 · price: Each performance share unit represented a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 3, 2023. F6 · derivative.expiration_date: The performance share units vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:23 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 4,065 | $84.49 | $343,451.85 |
DisclosureSEC source: 0001613103-23-000101 · wk-form4_1691454193.xml · nonDerivative · entry 2 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,965 F3 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:23 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 5,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000101 · wk-form4_1691454193.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,030 F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents. F2 · balance_after: Includes 61 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:22 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 64,185 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000084 · wk-form4_1691022114.xml · derivative · entry 3 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,185 Underlying: Ordinary Shares · 64,185 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:22 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 22,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000084 · wk-form4_1691022114.xml · derivative · entry 2 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,790 Underlying: Performance Share Unit · 22,790 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 22,790 shares will be issued. If maximum performance metrics are achieved, 45,580 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:22 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 9,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000084 · wk-form4_1691022114.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,156 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 544 units acquired through dividend reinvestment and 310 units acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 16:48 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 348 | $79.04 | $27,505.92 |
DisclosureSEC source: 0001127602-22-027200 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,186 F1 · balance_after: This balance increased by 183 shares due to exempt acquisitions through dividend reinvestment. F2 · balance_after: The reported transaction involved the withholding of 348 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:29 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 67,924 | $0.00 Strike: $93.08 | $0.00 |
DisclosureSEC source: 0001127602-22-020408 · form4.xml · derivative · entry 4 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,924 Underlying: Ordinary Shares · 67,924 shares Expires 2032-08-01 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:29 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 21,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020408 · form4.xml · derivative · entry 3 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,487 Underlying: Performance Share Units · 21,487 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,487 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on August 1, 2025. F5 · derivative.expiration_date: Vests on August 1, 2025. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:29 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 8,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020408 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,351 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 17:26 UTC | Medtronic plc MDT · Entity 2888 | Disposition to issuerOrdinary Shares | 12,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020201 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,756 F1 · shares: Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target. F2 · balance_after: This balance increased by 723 shares due to exempt acquisitions through dividend reinvestment and our employee stock purchase plan. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 18:31 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 7,218 | $102.04 | $736,524.72 |
DisclosureSEC source: 0001127602-21-031951 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,430 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 18:08 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 246 | $122.98 | $30,253.08 |
DisclosureSEC source: 0001127602-21-028744 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,648 F1 · balance_after: The reported transaction involved the withholding of 246 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. F2 · balance_after: This balance increased by 125 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:29 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 15,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023109 · form4.xml · derivative · entry 6 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,237 Underlying: Performance Share Units · 15,237 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,237 shares will be issued. The actual number of shares to be issued could range from a low of 3,048 at minimum performance to a high of 30,474 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F7 · derivative.exercise_date: Vests on August 2, 2024. F7 · derivative.expiration_date: Vests on August 2, 2024. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:29 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,085 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023109 · form4.xml · derivative · entry 5 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085 Underlying: Ordinary Shares · 1,085 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:29 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 52,074 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023109 · form4.xml · derivative · entry 4 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,074 Underlying: Ordinary Shares · 52,074 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:29 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 6,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023109 · form4.xml · nonDerivative · entry 2 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,769 F2 · kind: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:29 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 4,897 | $131.31 | $643,025.07 |
DisclosureSEC source: 0001127602-21-023109 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,674 F1 · balance_after: This balance increased by 649 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 17:06 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 10,930 | $115.46 | $1,261,977.80 |
DisclosureSEC source: 0001127602-20-032108 · form4.xml · nonDerivative · entry 3 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,922 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.43 to $115.52, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2020 Filed Dec 21, 2020 17:06 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-032108 · form4.xml · nonDerivative · entry 2 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 1,500 F1 · ownership.nature: These securities are owned by the White Family Legacy Trust. The reporting person is the co-trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| December 16, 2020 Filed Dec 21, 2020 17:06 UTC | Medtronic plc MDT · Entity 2888 | GiftOrdinary Shares | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-032108 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,852 Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 18:18 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 299 | $103.13 | $30,835.87 |
DisclosureSEC source: 0001127602-20-028284 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,352 F1 · balance_after: This balance increased by 159 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 09, 2020 Filed Oct 14, 2020 19:11 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 16,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026963 · form4.xml · derivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,563 Underlying: Performance Share Units · 16,563 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F2 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 16,563 shares will be issued. The actual number of shares to be issued could range from a low of 3,313 at minimum performance to a high of 33,126 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F3 · derivative.exercise_date: Vests on August 3, 2023. F3 · derivative.expiration_date: Vests on August 3, 2023. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:16 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 40,302 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022936 · form4.xml · derivative · entry 4 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,302 Underlying: Ordinary Shares · 40,302 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:16 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,575 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022936 · form4.xml · derivative · entry 3 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Ordinary Shares · 1,575 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:16 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 68,010 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022936 · form4.xml · derivative · entry 2 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,010 Underlying: Ordinary Shares · 68,010 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:16 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 7,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022936 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,492 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 18:11 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,727 | $96.48 | $263,100.96 |
DisclosureSEC source: 0001127602-20-022617 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,094 F1 · balance_after: This balance increased by 753 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 16:25 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 26,724 | $0.00 Strike: $74.84 | $0.00 |
DisclosureSEC source: 0001127602-19-034132 · form4.xml · derivative · entry 8 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 26,724 shares Expires 2025-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 16:25 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,442 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034132 · form4.xml · derivative · entry 7 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,442 shares Expires 2023-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 16:25 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 12,583 | $110.97 | $1,396,373.26 |
DisclosureSEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 6 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,068 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.76 to $111.54, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 16:25 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 12,859 | $110.28 | $1,418,090.52 |
DisclosureSEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 5 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,651 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.73 to $110.72, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 16:25 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 13,240 | $110.97 | $1,469,282.52 |
DisclosureSEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 4 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,510 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.73 to $111.51, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 16:25 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 13,484 | $110.29 | $1,487,082.94 |
DisclosureSEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 3 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,750 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.72 to $110.70, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 16:25 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 26,724 | $74.84 | $2,000,024.16 |
DisclosureSEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 2 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 16:25 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 25,442 | $47.00 | $1,195,774.00 |
DisclosureSEC source: 0001127602-19-034132 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,313 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · derivative · entry 11 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,442 Underlying: Ordinary Shares · 5,313 shares Expires 2023-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 37,209 | $0.00 Strike: $36.58 | $0.00 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · derivative · entry 10 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 37,209 shares Expires 2022-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,643 | $0.00 Strike: $29.52 | $0.00 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · derivative · entry 9 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,643 shares Expires 2021-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 1,964 | $109.66 | $215,378.13 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 8 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,068 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $110.01, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 3,349 | $109.11 | $365,419.44 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 7 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,032 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.46 to $109.43, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 5,313 | $47.00 | $249,711.00 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 6 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 14,662 | $109.67 | $1,607,937.55 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 5 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,068 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.45 to $110.18, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 28,428 | $109.11 | $3,101,722.22 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 4 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,730 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.44 to $109.44, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 37,209 | $36.58 | $1,361,105.22 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 3 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 3,762 | $109.66 | $412,537.16 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 2 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,949 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.46 to $109.98, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 18:28 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 9,643 | $29.52 | $284,661.36 |
DisclosureSEC source: 0001127602-19-031733 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: This balance increased by 151 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 16:54 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,995 | $0.00 Strike: $25.41 | $0.00 |
DisclosureSEC source: 0001127602-19-029740 · form4.xml · derivative · entry 12 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,995 shares Expires 2020-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 16:54 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,353 | $0.00 Strike: $29.52 | $0.00 |
DisclosureSEC source: 0001127602-19-029740 · form4.xml · derivative · entry 11 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,643 Underlying: Ordinary Shares · 27,353 shares Expires 2021-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.